Published in Women's Health Weekly, February 7th, 2008
"The benefits of extending therapy beyond 5 years has been established by the MA17 trial and many follow-on trials are...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.